MedPath

Contrast-enhanced MR imaging of the breast at 7T and 3T in the same patients.

Conditions
breast cancer, breast neoplasia
Registration Number
NL-OMON27773
Lead Sponsor
niversity Medical Center Utrecht (UMCU)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. 18 years or older;

2. Female patients;

Exclusion Criteria

1. Any prior surgery or radiotherapy to the ipsilateral breast;

2. Karnofsky score <= 70;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary aim is to assess the diagnostic performance of 7T CE breast MRI. This is done by comparing the final 7T BI-RADS-MRI classification to the final 3T BI-RADS-MRI classification and to histopathology obtained after biopsy and surgery.
Secondary Outcome Measures
NameTimeMethod
1. To establish the per-lesion diagnostic accuracy of 7T;<br /><br>2. Comparison of lesion size as determined at 7T, 3T and final pathology.
© Copyright 2025. All Rights Reserved by MedPath